ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$57.6M |
| 2 |
Intellia Therapeutics
NTLA
|
+$54.8M |
| 3 |
Stratasys
SSYS
|
+$44.4M |
| 4 |
Baidu
BIDU
|
+$42.2M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
+$34.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$31.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$14.8M |
| 3 |
FMI
Foundation Medicine, Inc.
FMI
|
+$12.6M |
| 4 |
Trip.com Group
TCOM
|
+$6.96M |
| 5 |
LendingTree
TREE
|
+$5.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.26% |
| 2 | Healthcare | 21.25% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Communication Services | 13.7% |
| 5 | Industrials | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IFX
76
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
| $1.95M | 0.1% |
+72,135
| New | +$1.95M |
|
77
PTC
PTC
$16B
| $1.92M | 0.1% |
24,616
+1,239
| +5% | +$90.4K |
|
78
Toyota
TM
$225B
| $1.82M | 0.09% |
13,984
-662
| -5% | -$88.7K |
|
79
Arcturus Therapeutics
ARCT
$211M
| $1.82M | 0.09% |
331,165
+254,428
| +332% | +$1.76M |
|
80
Cognex
CGNX
$11.3B
| $1.72M | 0.09% |
33,040
+15,092
| +84% | +$892K |
|
81
Albemarle
ALB
$15.5B
| $1.65M | 0.08% |
17,794
+9,461
| +114% | +$1.04M |
|
|
CSOD
82
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $1.59M | 0.08% |
40,712
+7,278
| +22% | +$295K |
|
83
Rockwell Automation
ROK
$49B
| $1.46M | 0.07% |
8,378
+2,101
| +33% | +$399K |
|
84
Alnylam Pharmaceuticals
ALNY
$29.3B
| $1.32M | 0.07% |
11,112
+9,014
| +430% | +$1.16M |
|
|
FPRX
85
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.18M | 0.06% |
68,854
+25,639
| +59% | +$500K |
|
86
Regeneron Pharmaceuticals
REGN
$80.8B
| $1.15M | 0.06% |
3,325
+564
| +20% | +$196K |
|
87
Iovance Biotherapeutics
IOVA
$2.87B
| $1.1M | 0.05% |
+65,096
| New | +$986K |
|
88
Pluri
PLUR
$19.6M
| $1.05M | 0.05% |
9,593
+5,956
| +164% | +$686K |
|
|
CFMS
89
DELISTED
Conformis, Inc. Common Stock
CFMS
| $1.02M | 0.05% |
28,126
+12,503
| +80% | +$525K |
|
|
KTWO
90
DELISTED
K2M Group Holdings, Inc
KTWO
| $954K | 0.05% |
50,347
-79,391
| -61% | -$1.57M |
|
91
SolarEdge
SEDG
$1.95B
| $843K | 0.04% |
16,022
+7,640
| +91% | +$335K |
|
92
WIX.com
WIX
$2.52B
| $783K | 0.04% |
9,838
+6,096
| +163% | +$428K |
|
|
FARO
93
DELISTED
Faro Technologies
FARO
| $720K | 0.04% |
12,327
-3,070
| -20% | -$170K |
|
|
MLNX
94
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $717K | 0.04% |
9,838
-48,418
| -83% | -$3.26M |
|
95
Ceragon Networks
CRNT
$201M
| $704K | 0.04% |
261,557
+137,820
| +111% | +$338K |
|
|
CYBR
96
DELISTED
CyberArk
CYBR
| $696K | 0.03% |
13,638
+7,828
| +135% | +$364K |
|
97
UroGen Pharma
URGN
$2.29B
| $671K | 0.03% |
13,502
+4,218
| +45% | +$211K |
|
|
NNDM
98
Nano Dimension
NNDM
$343M
| $667K | 0.03% |
35,840
+29,777
| +491% | +$814K |
|
|
ORBK
99
DELISTED
Orbotech Ltd
ORBK
| $660K | 0.03% |
10,613
+4,781
| +82% | +$262K |
|
100
Ametek
AME
$58.2B
| $659K | 0.03% |
8,677
-193
| -2% | -$14.7K |
|
Similar funds
ARK Investment Management's Q1 2018 Portfolio in Review
As of Q1 2018, ARK Investment Management held 213 positions worth $2.01B, up 60% from $1.26B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
ARK Investment Management deployed $731M of net new capital in Q1 2018, opening 13 new positions and adding to 155 existing holdings. Its largest new stake was TSMC: 217,209 shares worth $9.51M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $14.8M trimmed.
- ARK Investment Management's largest Q1 2018 buy was TSMC: 217,209 shares worth $9.51M.
- ARK Investment Management added most to Tesla in Q1 2018, an estimated $57.6M increase.
- ARK Investment Management's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $14.8M.
- ARK Investment Management fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $31.2M.
- ARK Investment Management's ten largest holdings make up 37% of its $2.01B portfolio in Q1 2018.
- ARK Investment Management opened 13 new positions and closed 14 in Q1 2018.
- ARK Investment Management's portfolio value rose 60% quarter-over-quarter to $2.01B.
Based on ARK Investment Management's 13F filing for Q1 2018, filed 14 May 2018.